经直肠前列腺活检前使用直肠培养选择性筛选培养基进行靶向抗菌预防的意义:一项多中心随机对照试验
这项多中心随机对照试验纳入403例感染并发症低风险的经直肠前列腺活检患者,随机分为培养组(CG)和无培养组(NCG)。CG中氟喹诺酮耐药或产超广谱β-内酰胺酶大肠埃希菌培养阳性者用哌拉西林/他唑巴坦预防,培养阴性者及NCG用左氧氟沙星。活检后前列腺炎总发生率为1.1%(n=4),CG为1.6%(n=3,均为培养阴性病例),NCG为0.5%(n=1),两组无显著差异(P=.3);培养阳性组无前列腺炎发生。左氧氟沙星不敏感选择性培养基的敏感性和特异性分别为98.1%和94.7%。
要点
- 经直肠前列腺活检后前列腺炎总发生率为1.1%(4/373)。
- 培养组前列腺炎发生率1.6% vs 无培养组0.5%,无显著差异(P=.3)。
- 培养阳性组无前列腺炎发生;检出氟喹诺酮耐药或产ESBL大肠埃希菌时可考虑哌拉西林/他唑巴坦。
核心结论
- 在感染并发症低风险患者中,经直肠前列腺活检前使用选择性培养基筛选可能为预防活检后前列腺炎提供附加价值。
- 当检出氟喹诺酮耐药或产超广谱β-内酰胺酶大肠埃希菌时,可考虑使用哌拉西林/他唑巴坦。
研究设计与样本
- 多中心随机对照试验,纳入403例接受经直肠前列腺活检且感染并发症低风险的患者,随机分为培养组(CG)和无培养组(NCG)。
- CG中氟喹诺酮耐药或产超广谱β-内酰胺酶大肠埃希菌培养阳性者使用哌拉西林/他唑巴坦预防,培养阴性者及NCG使用左氧氟沙星。
- 主要终点为经直肠前列腺活检后急性前列腺炎发生率,次要终点为选择性培养基的准确性。
主要发现
- 373例患者中(CG 187例,NCG 186例),CG中67例直肠培养阳性、120例阴性。
- 活检后前列腺炎总发生率为1.1%(n=4);CG为1.6%(n=3,均为培养阴性病例),NCG为0.5%(n=1),两组无显著差异(P=.3)。
- 培养阳性组无前列腺炎发生。
- 左氧氟沙星不敏感选择性培养基的敏感性为98.1%,特异性为94.7%。
临床怎么用
- 作者认为,在感染并发症低风险患者中,经直肠前列腺活检前使用选择性培养基筛选可能为预防活检后前列腺炎提供附加价值。
- 作者认为,当检出氟喹诺酮耐药或产超广谱β-内酰胺酶大肠埃希菌时,可考虑使用哌拉西林/他唑巴坦。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether antimicrobial prophylaxis based on screening rectal cultures using selective media prevented acute bacterial prostatitis following transrectal prostate biopsy (TRPB). METHODS: In this multicenter, randomized controlled trial, we enrolled 403 patients undergoing TRPB with low risks of infectious complications. Patients were randomized into a cultured group (CG) or no cultured group (NCG). In the CG, patients with positive-culture results for fluoroquinolone (FQ)-resistant or extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (E. coli) used piperacillin/tazobactam as prophylaxis, and those with negative-culture results and in the NCG used levofloxacin. The primary endpoint was the incidence of acute prostatitis after TRPB. The secondary endpoint was the accuracy of the selective media. RESULTS: Of 373 patients (CG, 187; NCG, 186), 67 were positive, and 120 were negative for rectal culture in the CG. The overall incidence of prostatitis after TRPB was 1.1% (n=4). The incidences in the CG and the NCG were 1.6% (n=3, all negative-culture cases) and 0.5% (n=1), respectively, without significant difference (P=.3). No prostatitis occurred in the positive-culture group. The sensitivity and specificity of the levofloxacin-insusceptible selective media were 98.1% and 94.7%, respectively. CONCLUSION: Screening with selective media before TRPB in patients with low infectious risks may provide additive value to preventing post-biopsy prostatitis. Piperacillin/tazobactam can be considered when FQ-resistant or ESBL-producing E. coli is detected.
引用
- Sadahira T, Sekito T, Maruyama Y, et al. Significance of Targeted Antimicrobial Prophylaxis Using Rectal-culture Selective Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial. Urology. 2024. PMID: 39694101. doi:10.1016/j.urology.2024.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。